MATTERHORN Archives

Dr. Josep Tabernero en el laboratorio con bata blanca VHIO

Immunotherapy in combination with standard-of-care chemotherapy before and after surgery demonstrates significant improvement in event-free survival in localized gastric and gastroesophageal junction cancers

Results from the MATTERHORN phase 3 study demonstrate that immunotherapy in combination with standard chemotherapy before and after surgery significantly…